These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 27739227)

  • 1. Insulin signalling in Alzheimer's disease and diabetes: from epidemiology to molecular links.
    Ribe EM; Lovestone S
    J Intern Med; 2016 Nov; 280(5):430-442. PubMed ID: 27739227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impairment of insulin signaling in Alzheimer's disease.
    Candeias E; Duarte AI; Carvalho C; Correia SC; Cardoso S; Santos RX; Plácido AI; Perry G; Moreira PI
    IUBMB Life; 2012 Dec; 64(12):951-7. PubMed ID: 23129399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 Diabetes Mellitus and Alzheimer's Disease: Role of Insulin Signalling and Therapeutic Implications.
    Tumminia A; Vinciguerra F; Parisi M; Frittitta L
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30355995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer's disease: studies in animal models.
    Calvo-Ochoa E; Arias C
    Diabetes Metab Res Rev; 2015 Jan; 31(1):1-13. PubMed ID: 24464982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.
    Hölscher C
    Biochem Soc Trans; 2011 Aug; 39(4):891-7. PubMed ID: 21787319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: Common Molecular Mechanism and Therapeutic Targets.
    Chauhan A; Dubey S; Jain S
    Cell Biochem Funct; 2024 Sep; 42(7):e4111. PubMed ID: 39228117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared links between type 2 diabetes mellitus and Alzheimer's disease: A review.
    Mittal K; Katare DP
    Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S144-9. PubMed ID: 26907971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease.
    Kang S; Lee YH; Lee JE
    Yonsei Med J; 2017 May; 58(3):479-488. PubMed ID: 28332351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets.
    Hamzé R; Delangre E; Tolu S; Moreau M; Janel N; Bailbé D; Movassat J
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation.
    Correia SC; Santos RX; Carvalho C; Cardoso S; Candeias E; Santos MS; Oliveira CR; Moreira PI
    Brain Res; 2012 Mar; 1441():64-78. PubMed ID: 22290178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.
    Moreira PI; Santos MS; Seiça R; Oliveira CR
    J Neurol Sci; 2007 Jun; 257(1-2):206-14. PubMed ID: 17316694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rise and fall of insulin signaling in Alzheimer's disease.
    Chami B; Steel AJ; De La Monte SM; Sutherland GT
    Metab Brain Dis; 2016 Jun; 31(3):497-515. PubMed ID: 26883429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease.
    Ferreira ST; Clarke JR; Bomfim TR; De Felice FG
    Alzheimers Dement; 2014 Feb; 10(1 Suppl):S76-83. PubMed ID: 24529528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focus on the Correlations between Alzheimer's Disease and Type 2 Diabetes.
    Fiore V; De Rosa A; Falasca P; Marci M; Guastamacchia E; Licchelli B; Giagulli VA; De Pergola G; Poggi A; Triggiani V
    Endocr Metab Immune Disord Drug Targets; 2019; 19(5):571-579. PubMed ID: 30854980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective Insulin Signalling, Mediated by Inflammation, Connects Obesity to Alzheimer Disease; Relevant Pharmacological Therapies and Preventive Dietary Interventions.
    Rodriguez-Casado A; Toledano-Díaz A; Toledano A
    Curr Alzheimer Res; 2017; 14(8):894-911. PubMed ID: 28317485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria and Oxidative Stress as a Link between Alzheimer's Disease and Diabetes Mellitus.
    Veselov IM; Vinogradova DV; Maltsev AV; Shevtsov PN; Spirkova EA; Bachurin SO; Shevtsova EF
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain insulin, insulin-like growth factor 1 and glucagon-like peptide 1 signalling in Alzheimer's disease.
    Ferreira ST
    J Neuroendocrinol; 2021 Apr; 33(4):e12959. PubMed ID: 33739563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 Diabetes Mellitus and Alzheimer's Disease: A Review of the Potential Links.
    Pakdin M; Toutounchian S; Namazi S; Arabpour Z; Pouladi A; Afsahi S; Poudineh M; Nasab MMM; Yaghoobpoor S; Deravi N
    Curr Diabetes Rev; 2022; 18(8):e051121197760. PubMed ID: 34749616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired insulin signaling and the pathogenesis of Alzheimer's disease.
    Revill P; Moral MA; Prous JR
    Drugs Today (Barc); 2006 Dec; 42(12):785-90. PubMed ID: 17285151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.